Liver Cancer

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Liver Cancer Information Center has current, evidence-based information for you. Get the facts about liver cancer prevention, early detection, treatment, and survivorship, and stay up to date with ongoing liver cancer research that could impact your treatment decisions through our daily cancer news.

CancerConnect Liver Community & Discussions

You are not alone—The CancerConnect Liver Community is the leading Social Media Application for Liver patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.

LIVER CANCER NEWS TIPS & FEATURES

Pass It On: It’s National Liver Cancer Awareness Month

October 10th, 2016

Pass It On: It’s National Liver Cancer Awareness Month

As the month of October brings liver cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening […]


Daiichi Sankyo and ArQule Announce Continuation of METIV-HCC Phase 3 Study of Tivantinib in Second-Line Hepatocellular Carcinoma

April 5th, 2016

Daiichi Sankyo and ArQule Announce Continuation of METIV-HCC Phase 3 Study of Tivantinib in Second-Line Hepatocellular Carcinoma

Daiichi Sankyo announced that the independent data monitoring committee of the METIV-Hepatocellular cancer (HCC) study conducted a planned interim assessment and it was determined the […]


February: Gallbladder and Bile Duct Awareness Month

February 18th, 2016

February: Gallbladder and Bile Duct Awareness Month

Located underneath the liver, the gallbladder is responsible for the concentration and storage of bile which helps to digest the fats in food as they pass […]


Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents

February 11th, 2016

Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents

The United States Food and Drug Administration (FDA) approved Vistogard (uridine triacetate) for the treatment of life-threatening toxicities caused by the chemotherapy drugs fluorouracil or […]


New Care Approach to Liver Operations Speeds Patient Recovery

October 29th, 2015

New Care Approach to Liver Operations Speeds Patient Recovery

Patients undergoing oncologic liver operations who participated in an enhanced recovery program returned sooner to their normal life function and adjuvant cancer therapies than patients […]


Infection with Hepatitis C Increases Risk of Cirrhosis

March 10th, 2015

Infection with Hepatitis C Increases Risk of Cirrhosis

People who are infected with the hepatitis C virus (HCV) have a higher risk for developing the liver disease cirrhosis, particularly within the first five […]


OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine

August 13th, 2014

OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine

Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition of its online support communities, TheGIConnection,TheRAConnection, and Cancer Connect, as valuable resources for […]


Hepatitis C Cases Could Be Cured By Novel Oral Drug Regimen

July 31st, 2014

Hepatitis C Cases Could Be Cured By Novel Oral Drug Regimen

According to the results of two new clinical studies published in The Lancet, two new pill-only antiviral drug regimens for hepatitis C virus infection provide shorter […]


Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation

May 27th, 2014

Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation

The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after […]


Liver Cancer Screening Improves Survival Rates Among Cirrhosis Patients, Says UT Southwestern Researcher

May 15th, 2014

Liver Cancer Screening Improves Survival Rates Among Cirrhosis Patients, Says UT Southwestern Researcher

A recent review by doctors at University of Texas Southwestern Medical Center has shown thatliver cancer survival rates could be improved if people with cirrhosis are more frequently […]


More News →